Triclosan Concern In Congress Spurs Call For Final Antimicrobial Monograph
This article was originally published in The Tan Sheet
Executive Summary
Concern about the safety of triclosan prompts a lawmaker to pressure FDA to finalize the OTC Topical Antimicrobial Drug monograph, first proposed in 1972
You may also be interested in...
Consent Decree Orders FDA Action On Triclosan OTC Monographs
A Nov. 21 consent decree sets multiple deadlines over a five-year period to make FDA finalize its OTC topical antimicrobial drug products monograph with respect to triclosan. Under one deadline of note to triclosan product makers, the agency must publish a tentative final monograph for consumer antiseptic hand wash products by Dec. 16, with a final monograph due by Sept. 15, 2016.
Consent Decree Orders FDA Action On Triclosan OTC Monographs
A Nov. 21 consent decree sets multiple deadlines over a five-year period to make FDA finalize its OTC topical antimicrobial drug products monograph with respect to triclosan. Under one deadline of note to triclosan product makers, the agency must publish a tentative final monograph for consumer antiseptic hand wash products by Dec. 16, with a final monograph due by Sept. 15, 2016.
Researchers Suggest Reducing Triclosan Use Following NIH-Funded Study
The study exploring the impact of triclosan on cardiac and skeletal muscle function in animals prompts researchers to call for a “dramatic reduction” of the ingredient in consumer products. Industry says the study used “unrealistically large” doses of the antibacterial ingredient that do not represent real-world conditions.